Note: Ingredients listed on restricted chemical lists
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
General Information
Product name
ADRIAMYCIN (DOXOrubicin HCl) Injection, USP
Chemical name
Doxorubicin hydrochloride is (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-L-lyxo- hexopyranosyl)-oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5, 12-naphthacene¬dione hydrochloride
1.2.1 Relevant identified uses
Adriamycin (DOXOrubicin HCl) Injection, USP is indicated as a component of multi- agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer
supplier name
Hikma Pharmaceuticals USA Inc
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Hikma Pharmaceuticals USA Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
CARCINOGENICITY - Category 1B
Signal word
Danger
Hazard statements
H350 - May cause cancer.
Prevention
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves. Wear eye or face protection. Wear protective clothing.
Response
P308 + P313 - IF exposed or concerned: Get medical attention.
Storage
P405 - Store locked up.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
2.3 Other hazards
None known.